Renflexis® requires authorization for BCN AdvantageSM starting Oct. 1

For dates of service on or after Oct. 1, 2018, Renflexis requires authorization for BCN Advantage members.

This medication is not self-administered. It must be given by injection or infusion by a physician or health care professional in the office, home or outpatient facility setting.

This medication requires authorization when it is billed on either a professional HCFA 1500 claim form (or submitted electronically using an 837P transaction) or on a facility claim form such as the UB-04 (or submitted electronically using an 837I transaction), for the following places of service:

Submit authorization requests for this medication through the Novologix online tool. Authorization must be obtained prior to the medication being administered.

Posted: September 2018
Line of business: Blue Care Network